Skip to main content

Table 2 Summary data for the 61 participants of the MTM-HD study

From: Abnormal molecular signatures of inflammation, energy metabolism, and vesicle biology in human Huntington disease peripheral tissues

HD status

Site

Gender

Age [years]

Short CAG allele

Long CAG allele

DBS

Weight [kg]

Height [cm]

BMI

TFC

TMS

FA

IS

Control

1: 10

2: 10

f: 10

m: 10

41.3

[31.6;

55.9]

15.2

[10;20]

18.5

[15;27]

n.a.

74.4

[45.3;102]

171.7

[158;187]

25.1

[17.6;33.7]

13

[13;13]

0.5

[0;4]

25

[25;25]

100

[100;100]

Pre-HD

1: 10

2: 11

f: 10

m: 11

41.6

[31.2;

56.5]

19.6

[9;24]

43.6

[40;48]

327.7

[158.6;

423.8]

76.2

[49.2;115]

172.8

[154;190]

25.4

[20.4;35.5]

12.7

[11;13]

5.3

[0;18]

24.7

[22;25]

97.6

[80;100]

Early-HD

1: 10

2: 10

f: 10

m: 10

45.4

[35.4;

58.9]

18.9

[9;25]

44.5

[41;50]

406.7

[281.0;

657.3]

73.7

[55;94.4]

173.5

[153;197]

24.4

[18.6;27.9]

10.9

[7;13]

24

[8;49]

22.3

[16;25]

88.4

[70;100]

  1. Data are mean and minimal and maximal values, respectively, in brackets. Abbreviations: Gender: f female, m male. DBS disease burden score (not applicable (n.a.) in the control group). BMI body mass index, TFC total functional capacity, TMS total motor score, FA function analysis, IS independence scale